Sravanthi Koduri, Aditya Pandey, Neeraj Chaudhary, Guohua Xi, Thomas L Chenevert, Momodou G Bah, Ehsan Dowlati, Max Fleigner, Leanne Y Lin, Jonathan Troost, Richard Keep
Journal: Neuroimaging clinics of North America 2024;34(2):215-224
PMID: 38604706
This review article discusses the role of MR imaging-based biomarkers in understanding and managing hemorrhagic strokes, focusing on intracerebral hemorrhage (ICH) and aneurysmal subarachnoid hemorrhage. ICH is a severe type of stroke with high mortality and morbidity rates, primarily caused by the rupture of small blood vessels in the brain, resulting in hematoma formation. MR imaging-based biomarkers, including brain iron quantification, ultra-early erythrolysis detection, and diffusion tensor imaging, offer valuable insights for hemorrhagic stroke management. These biomarkers could improve early diagnosis, risk stratification, treatment monitoring, and patient outcomes in the future, revolutionizing our approach to hemorrhagic strokes.
Copyright © 2024 Elsevier Inc. All rights reserved.
Medical:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.